Thure Krarup

Medicine & Life Sciences

1. Type 2 Diabetes Mellitus 100%
2. Insulin 71%
3. Glucagon-Like Peptide 1 70%
4. Glucose 63%
5. Incretins 53%
6. High-Protein Diet 38%
7. Carbohydrates 38%
8. Hypoglycemia 38%
9. Metformin 33%
10. Dietary Carbohydrates 27%
11. Meals 27%
12. Insulin Secretion 27%
13. Glucagon 27%
14. Peptides 25%
15. Diet 24%
16. Exenatide 22%
17. Randomized Controlled Trials 22%
18. Chronic Pancreatitis 21%
19. Hormones 20%
20. Placebos 17%
21. Weight Loss 16%
22. Fasting 15%
23. Glucose Tolerance Test 14%
24. Healthy Volunteers 14%
25. Carotid Intima-Media Thickness 14%
26. Liraglutide 13%
27. Blood Glucose 13%
28. C-Peptide 12%
29. Type 1 Diabetes Mellitus 12%
30. Fats 12%
31. Body Weight 11%
32. Pancreatic Polypeptide 10%
33. Glucose Intolerance 10%
34. Glucagon-Like Peptide 2 10%
35. Area Under Curve 10%
36. Therapeutics 10%
37. Diabetic Neuropathies 9%
38. Insulin Resistance 9%
39. Gastrointestinal Hormones 9%
40. Weights and Measures 8%
41. Breakfast 8%
42. Sitagliptin Phosphate 8%
43. Insulin-Secreting Cells 7%
44. Hypoglycemic Agents 7%
45. gastric inhibitory polypeptide (3-42) 7%
46. blood group A active hexaglycosylceramide type 2 chain 7%
47. Carbohydrate-Restricted Diet 7%
48. Dipeptidyl Peptidase 4 6%
49. Lunch 6%
50. B-Lymphocytes 6%